ClinicalTrials.Veeva

Menu

Trendelenburg, Abdominal Insufflation and Time to Completion of Cystoscopy

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

Ureteral Integrity
Bladder Integrity
Ureteral Function
Bladder Function

Treatments

Device: Insufflation
Other: Trendelenburg position
Other: Flat position

Study type

Interventional

Funder types

Other

Identifiers

NCT05786391
HSC-MS-22-1081

Details and patient eligibility

About

Objective:

The investigators seek to compare the efficiency of the cystoscopy with two interventions:

  1. patient position during the cystoscopy (Trendelenburg (head down) or flat)
  2. Abdominal insufflation (insufflation versus no insufflation)

Full description

This is a randomized controlled trial assessing time to completion of cystoscopy in seconds after minimally invasive gynecologic surgery.

The investigators seek to compare the efficiency of the cystoscopy with two interventions:

  1. patient position during the cystoscopy (Trendelenburg (head down) or flat)
  2. Abdominal insufflation (insufflation versus no insufflation).

Both interventions are used as usual care and depend on surgeon preference without evidence why one would be faster at completing the cystoscopy. Also note that these two interventions are performed multiple times during the surgery itself and outside the cystoscopy procedure routinely. The investigator's main objective is to assess which intervention or combination of interventions is more efficient.

Enrollment

122 patients

Sex

Female

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patient undergoing Planned cystoscopy in the benign gynecology service, (specifically undergoing a laparoscopic or robotic procedure requiring insufflation).

Exclusion criteria

  • Pregnancy
  • Known urologic anomaly
  • Unplanned cystoscopy
  • Cancer surgery
  • Urogynecology surgery
  • comorbidities including cardiac disease, chronic hypertension, any stage kidney disease (including abnormal creatinine level), and use of diuretics.
  • Undergoing extensive ureterolysis
  • Blood loss more than 500 milliliters (mLs)
  • Contra-indications to position change and insufflation

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

122 participants in 4 patient groups

Flat position with no Insufflation
Experimental group
Treatment:
Other: Flat position
Trendelenburg position and Insufflation
Experimental group
Description:
insufflation to 15 mm Hg
Treatment:
Other: Trendelenburg position
Device: Insufflation
Flat position and Insufflation
Experimental group
Treatment:
Other: Flat position
Device: Insufflation
Trendelenburg position with no Insufflation
Experimental group
Treatment:
Other: Trendelenburg position

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Sunbola Ashimi, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems